Metipranolol
Back to searchMolecule Structure
Scientific Name
Metipranolol
Description of the Drug
Metipranolol is a beta-adrenergic antagonist used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01214
http://www.drugbank.ca/drugs/DB01214
Brand Name(s)
Glauline, Optipranolol
Company Owner(s)
Sandoz Inc, Bausch And Lomb Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24324 | |
| PharmGKB | PA164748727 | |
| Human Metabolome Database | HMDB0015345 | |
| DrugBank | DB01214 | |
| PubChem: Thomson Pharma | 14923317 | |
| PubChem | 31477 | |
| Mcule | MCULE-4113586715 | |
| Nikkaji | J11.486C | |
| EPA CompTox Dashboard | DTXSID4046078 | |
| DrugCentral | 1779 | |
| ChemicalBook | CB2880767 | |
| Guide to Pharmacology | 7239 | |
| rxnorm | METIPRANOLOL | METIPRANOLOL HYDROCHLORIDE |
| KEGG Ligand | C07915 | |
| ChEBI | 6897 |
